These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3149503)

  • 21. An active zymogen: unravelling the mystery of tissue-type plasminogen activator.
    Stubbs MT; Renatus M; Bode W
    Biol Chem; 1998 Feb; 379(2):95-103. PubMed ID: 9524060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of the binding site of tissue-type plasminogen activator to fibrin.
    Ichinose A; Takio K; Fujikawa K
    J Clin Invest; 1986 Jul; 78(1):163-9. PubMed ID: 3088041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.
    de Munk GA; Caspers MP; Chang GT; Pouwels PH; Enger-Valk BE; Verheijen JH
    Biochemistry; 1989 Sep; 28(18):7318-25. PubMed ID: 2510823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.
    Lamba D; Bauer M; Huber R; Fischer S; Rudolph R; Kohnert U; Bode W
    J Mol Biol; 1996 Apr; 258(1):117-35. PubMed ID: 8613982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variants of human tissue-type plasminogen activator substituted at the protease cleavage site and glycosylation sites, and truncated at the N- and C-termini.
    Haigwood NL; Mullenbach GT; Moore GK; DesJardin LE; Tabrizi A; Brown-Shimer SL; Stauss H; Stöhr HA; Pâques EP
    Protein Eng; 1989 Aug; 2(8):611-20. PubMed ID: 2510149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin.
    Soeda S; Kakiki M; Shimeno H; Nagamatsu A
    Biochim Biophys Acta; 1987 Dec; 916(3):279-87. PubMed ID: 3120775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of substituted laminin A chain-derived peptides on the conformation and activation kinetics of plasminogen.
    Stack MS; Pizzo SV
    Arch Biochem Biophys; 1994 Feb; 309(1):117-22. PubMed ID: 8117101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trinitrobenzoylated poly(D-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator.
    Petersen LC; Suenson E
    Biochim Biophys Acta; 1986 Sep; 883(2):313-25. PubMed ID: 2943320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of plasminogen activation by recombinant cellular prion protein is conserved in the NH2-terminal fragment PrP23-110.
    Praus M; Kettelgerdes G; Baier M; Holzhütter HG; Jungblut PR; Maissen M; Epple G; Schleuning WD; Köttgen E; Aguzzi A; Gessner R
    Thromb Haemost; 2003 May; 89(5):812-9. PubMed ID: 12719777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct mechanisms contribute to stringent substrate specificity of tissue-type plasminogen activator.
    Coombs GS; Dang AT; Madison EL; Corey DR
    J Biol Chem; 1996 Feb; 271(8):4461-7. PubMed ID: 8626799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of human tissue-type plasminogen activator with monoclonal antibodies: mapping of epitopes and binding sites for fibrin and lysine.
    Zacharias U; Fischer B; Noll F; Will H
    Thromb Haemost; 1992 Jan; 67(1):88-94. PubMed ID: 1377416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator (t-PA) and fibrin-dependent enhancement of amidolytic activity of t-PA.
    Fischer BE
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):197-204. PubMed ID: 1606292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-glycosylation and in vitro enzymatic activity of human recombinant tissue plasminogen activator expressed in Chinese hamster ovary cells and a murine cell line.
    Parekh RB; Dwek RA; Rudd PM; Thomas JR; Rademacher TW; Warren T; Wun TC; Hebert B; Reitz B; Palmier M
    Biochemistry; 1989 Sep; 28(19):7670-9. PubMed ID: 2514793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of recombinant tissue-type plasminogen activator (rt-PA) expressed in mouse C127 cells and human vascular plasminogen activator (HV-PA).
    Hamaguchi M; Takahashi I; Takehara T; Takamatsu J; Saito H
    Biochim Biophys Acta; 1989 Nov; 1009(2):143-50. PubMed ID: 2508748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assignment of the binding site for tissue plasminogen activator on human fibronectin.
    Wang L; Lin XH; Cui DF; Wang ZY; Chi CW
    J Biol Chem; 1994 Feb; 269(6):4332-6. PubMed ID: 8308001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrate specificity of tissue-type and urokinase-type plasminogen activators.
    Rijken DC; Groeneveld E
    Biochem Biophys Res Commun; 1991 Jan; 174(2):432-8. PubMed ID: 1899564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational similarities between one-chain and two-chain tissue plasminogen activator (t-PA): implications to the activation mechanism on one-chain t-PA.
    Nienaber VL; Young SL; Birktoft JJ; Higgins DL; Berliner LJ
    Biochemistry; 1992 Apr; 31(15):3852-61. PubMed ID: 1314651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa.
    Grundy JE; Lavigne N; Hirama T; MacKenzie CR; Pryzdial EL
    Biochemistry; 2001 May; 40(21):6293-302. PubMed ID: 11371191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1.
    Madison EL; Goldsmith EJ; Gerard RD; Gething MJ; Sambrook JF; Bassel-Duby RS
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3530-3. PubMed ID: 2110366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain.
    Stack MS; Gray RD; Pizzo SV
    Cancer Res; 1993 May; 53(9):1998-2004. PubMed ID: 8481902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.